Peter Haddad

13.6k total citations · 4 hit papers
180 papers, 7.9k citations indexed

About

Peter Haddad is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Peter Haddad has authored 180 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Psychiatry and Mental health, 48 papers in Clinical Psychology and 37 papers in Pharmacology. Recurrent topics in Peter Haddad's work include Schizophrenia research and treatment (62 papers), Treatment of Major Depression (36 papers) and Bipolar Disorder and Treatment (35 papers). Peter Haddad is often cited by papers focused on Schizophrenia research and treatment (62 papers), Treatment of Major Depression (36 papers) and Bipolar Disorder and Treatment (35 papers). Peter Haddad collaborates with scholars based in United Kingdom, Qatar and United States. Peter Haddad's co-authors include Angelika Wieck, Ian Anderson, Jan Scott, Christoph U. Correll, Cecilia Brain, Mark Taylor, Serdar Dursun, Maxine X. Patel, Pasi K. Korhonen and Jari Haukka and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Peter Haddad

166 papers receiving 7.5k citations

Hit Papers

Evidence-based guidelines... 2011 2026 2016 2021 2015 2011 2014 2016 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Haddad 4.8k 1.6k 1.4k 793 655 180 7.9k
Miquel Bernardo 5.5k 1.1× 1.5k 0.9× 994 0.7× 844 1.1× 527 0.8× 406 8.8k
Charles M. Beasley 5.8k 1.2× 1.4k 0.9× 2.5k 1.8× 970 1.2× 431 0.7× 145 8.1k
Michael Gitlin 5.5k 1.1× 2.3k 1.4× 1.1k 0.7× 546 0.7× 708 1.1× 151 8.3k
W. Wolfgang Fleischhacker 7.2k 1.5× 2.1k 1.3× 1.2k 0.9× 1.5k 1.9× 979 1.5× 266 11.1k
John Hsiao 7.8k 1.6× 1.8k 1.1× 1.3k 0.9× 1.5k 1.9× 740 1.1× 78 10.9k
William H. Carson 7.0k 1.4× 1.5k 0.9× 1.9k 1.3× 742 0.9× 236 0.4× 141 8.8k
Leslie Citrome 8.9k 1.8× 2.9k 1.8× 2.1k 1.4× 1.1k 1.4× 564 0.9× 435 13.3k
Joanne B. Severe 7.5k 1.5× 3.6k 2.2× 903 0.6× 1.2k 1.5× 759 1.2× 39 9.9k
Robin Emsley 5.2k 1.1× 2.4k 1.5× 746 0.5× 1.4k 1.8× 954 1.5× 281 8.5k
Dan Siskind 3.3k 0.7× 2.4k 1.5× 681 0.5× 516 0.7× 871 1.3× 247 8.2k

Countries citing papers authored by Peter Haddad

Since Specialization
Citations

This map shows the geographic impact of Peter Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Haddad more than expected).

Fields of papers citing papers by Peter Haddad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Haddad. The network helps show where Peter Haddad may publish in the future.

Co-authorship network of co-authors of Peter Haddad

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Haddad. A scholar is included among the top collaborators of Peter Haddad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Haddad. Peter Haddad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quirk, Shae E., et al.. (2024). Barriers and facilitators to mental health treatment access and engagement for LGBTQA+ people with psychosis: a scoping review protocol. Systematic Reviews. 13(1). 143–143. 1 indexed citations
2.
Zolezzi, Monica, et al.. (2021). Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile. Neuropsychiatric Disease and Treatment. Volume 17. 1917–1926. 9 indexed citations
3.
Chaudhry, Imran B., Muhammad Omair Husain, Ameer B. Khoso, et al.. (2021). Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. Translational Psychiatry. 11(1). 1 indexed citations
4.
Chaudhry, Imran B., Muhammad Omair Husain, Ameer B. Khoso, et al.. (2020). A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. Translational Psychiatry. 10(1). 415–415. 40 indexed citations
5.
Green, A. Richard, Peter Haddad, & Jeffrey K Aronson. (2018). Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950–1980). British Journal of Clinical Pharmacology. 84(8). 1668–1685. 5 indexed citations
6.
Green, A. Richard, Jeffrey K Aronson, & Peter Haddad. (2018). Examining the ‘psychopharmacology revolution’ (1950–1980) through the advertising of psychoactive drugs in the British Medical Journal. Journal of Psychopharmacology. 32(10). 1056–1066. 3 indexed citations
7.
Wickramasinghe, Nilmini & Peter Haddad. (2017). Using healthcare information systems to facilitate smart and sustainable knowledge flow in healthcare: the case of allergy care in Australia. Journal of the Association for Information Systems. 2814–2824. 1 indexed citations
8.
Paddle, Paul, et al.. (2017). THE DEVELOPMENT OF A HOSPITAL SECURE MESSAGING AND COMMUNICATION PLATFORM: A CONCEPTUALIZATION. Journal of the Association for Information Systems. 2699–2710. 1 indexed citations
9.
Haddad, Peter, et al.. (2016). Assessing the Business Value of Australia’s National e-health Solution. Own your potential (DEAKIN). 1 indexed citations
10.
Nguyen, Lemai, et al.. (2015). Developing an Information System for Nursing in Acute Care Contexts. Journal of the Association for Information Systems. 219. 1 indexed citations
11.
Haddad, Peter, et al.. (2015). Identifying key success factors for the adoption and implementation of a chemotherapy ordering system: A case study from the Australian private healthcare sector. Journal of the Association for Information Systems. 1–15.
12.
Haddad, Peter, et al.. (2014). Evaluating business value of IT in healthcare in Australia: the case of an intelligent operational planning support tool solution. Journal of the Association for Information Systems. 17.
13.
Haddad, Peter & Nilmini Wickramasinghe. (2014). Conceptualizing Business Value of IT in Healthcare to Design Sustainable e-Health Solutions. Journal of the Association for Information Systems. 2 indexed citations
14.
McAllister‐Williams, R. Hamish, Eleanor Smith, Ian Anderson, et al.. (2013). Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). BMC Psychiatry. 13(1). 205–205. 10 indexed citations
15.
McAllister‐Williams, R. Hamish, David S. Baldwin, Peter Haddad, & Stephen Bazire. (2010). The use of antidepressants in clinical practice: focus on agomelatine. Human Psychopharmacology Clinical and Experimental. 25(2). 95–102. 35 indexed citations
16.
Haddad, Peter, et al.. (2008). The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. Journal of Psychopharmacology. 22(3). 330–332. 76 indexed citations
17.
Pérahia, David, Daniel K. Kajdasz, D. Desaiah, & Peter Haddad. (2005). Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. Journal of Affective Disorders. 89(1-3). 207–212. 63 indexed citations
18.
Bird, Diane, Peter Haddad, & Serdar Dursun. (2002). An Overview of The Definition and Management of Treatment-Resistant Depression. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 12(2). 92–101. 9 indexed citations
19.
Schatzberg, Alan F., Peter Haddad, Michel Lejoyeux, et al.. (1997). Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Hypothetical Definition. The Journal of Clinical Psychiatry. 58. 5–10. 62 indexed citations
20.
Schatzberg, Alan F., Peter Haddad, Michel Lejoyeux, et al.. (1997). Possible Biological Mechanisms of the Serotonin Reuptake Inhibitor Discontinuation Syndrome. The Journal of Clinical Psychiatry. 58. 23–27. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026